TY - DATA T1 - Additional file 3: of Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection PY - 2016/12/12 AU - Milos Ikonomovic AU - Chris Buckley AU - Kerstin Heurling AU - Paul Sherwin AU - Paul Jones AU - Michelle Zanette AU - Chester Mathis AU - William Klunk AU - Aruna Chakrabarty AU - James Ironside AU - Azzam Ismail AU - Colin Smith AU - Dietmar Thal AU - Thomas Beach AU - Gill Farrar AU - Adrian Smith UR - https://springernature.figshare.com/articles/journal_contribution/Additional_file_3_of_Post-mortem_histopathology_underlying_-amyloid_PET_imaging_following_flutemetamol_F_18_injection/4316747 DO - 10.6084/m9.figshare.c.3595850_D4.v1 L4 - https://ndownloader.figshare.com/files/7040231 KW - Flutemetamol KW - PET KW - Amyloid KW - Alzheimer’s disease KW - Neuropathology (4-6 allowed) N2 - ROC Analysis - Dichotomised BIE (majority read) vs categorical neuropathology. Comparison of the 4 histopathological criteria of assigning abnormal amyloid against a dichotomised (Abnormal/Normal) majority blinded PET Image evaluation. The 4 criteria shown are CERAD [43], National Institutes of Ageing – Reagan Institute AD diagnosis [26], National Institutes of Ageing – Alzheimer’s Association AD diagnosis [25] and Amyloid phase (Phase 3 or greater) [58]. (DOC 201 kb) ER -